Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 17, 2025 08:00 ET | Source: Agios Pharmaceuticals, Inc.

Agios’ PYRUKYND® (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia

Agios today announced that the CHMP has adopted a positive opinion for the new indication for PYRUKYND in adults for anemia associated with thalassemia
October 02, 2025 07:00 ET | Source: Draig Therapeutics

Draig Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of DT-101 for the Treatment of Major Depressive Disorder

DT-101 is designed to allow effective modulation of the AMPA receptor without compromising safetyPhase 2 clinical trial initiation anticipated before the end of 2025Trial builds on positive Phase 1...
September 17, 2025 02:00 ET | Source: Opterion Health AG

Opterion Health AG submits Clinical Trial Application for First-in-Human Study of OPT101 in Patients with Advanced Chronic Kidney Disease

MUTTENZ, Switzerland, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company developing OPT101 as an innovative treatment for patients on peritoneal...
September 04, 2025 07:00 ET | Source: Agios Pharmaceuticals, Inc.

Agios Provides Update on U.S. PDUFA Goal Date for PYRUKYND® (mitapivat) in Thalassemia

Agios announced that the U.S. FDA has extended the PDUFA goal date for the sNDA of PYRUKYND for adults with thalassemia by three months to December 7, 2025
September 02, 2025 04:15 ET | Source: Hemex AG

Hemex expands Global Clinical Network Alliance to strengthen end-to-end CRO Capabilities

A newly established global alliance integrating specialized expertise in oncology, medical imaging, patient recruitment as well as pharmacokinetics and pharmacodynamics studiesComprehensive access to...
August 25, 2025 12:21 ET | Source: Recor Medical

Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension

Palo Alto, CA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced today that the Paradise™ Ultrasound Renal...
August 25, 2025 12:08 ET | Source: Recor Medical

Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension

Palo Alto, CA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced today that the Paradise™ Ultrasound Renal...
August 05, 2025 10:03 ET | Source: Metrc LLC

Metrc and BioTrack Announce Strategic Partnership to Advance Cannabis Technology Solutions

LAKELAND, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Metrc, a leading provider of regulatory track-and-trace systems for highly regulated industries, announced a strategic partnership with BioTrack, a...
August 04, 2025 16:01 ET | Source: Agios Pharmaceuticals, Inc.

Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia

Agios Pharmaceuticals today announced that the Saudi Food and Drug Authority has approved PYRUKYND® for the treatment of adult patients with thalassemia
July 17, 2025 13:20 ET | Source: Hunton Andrews Kurth

Centre for Information Policy Leadership Announces Agreement with Stephen Almond to Join as Vice President of Policy and Consulting

London, July 17, 2025 (GLOBE NEWSWIRE) -- The Centre for Information Policy Leadership (CIPL), a global data and privacy think tank founded in 2001 by leading companies and Hunton Andrews Kurth LLP,...